We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+14.91%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$242M
AUM Growth
+$46.8M
Cap. Flow
+$26.1M
Cap. Flow %
10.78%
Top 10 Hldgs %
46.63%
Holding
110
New
24
Increased
21
Reduced
24
Closed
20

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$2.39M
2
BABA icon
Alibaba
BABA
+$1.94M
3
GILD icon
Gilead Sciences
GILD
+$1.72M
4
ABBV icon
AbbVie
ABBV
+$1.63M
5
KWEB icon
KraneShares CSI China Internet ETF
KWEB
+$1.48M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.43M
2
IBB icon
iShares Biotechnology ETF
IBB
+$1.35M
3
CSCO icon
Cisco
CSCO
+$1.18M
4
VZ icon
Verizon
VZ
+$1.14M
5
XLNX
Xilinx Inc
XLNX
+$1.04M

Sector Composition

Rank Sector Weight
1 Healthcare 32.28%
2 Technology 13.29%
3 Communication Services 7.57%
4 Financials 4.7%
5 Consumer Discretionary 2.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KSS icon
76
Kohl's
KSS
$2.17B
$407K 0.17%
10,000
– –
QCOM icon
77
Qualcomm
QCOM
$155B
$381K 0.16%
2,500
– –
BABA icon
78
CALL
Alibaba
BABA
$293B
$349K 0.14%
+1,500
New +$416K
NOK icon
79
CALL
Nokia
NOK
$51B
$338K 0.14%
86,500
– –
AYX
80
CALL
DELISTED
Alteryx Inc
AYX
$304K 0.13%
+2,500
New +$315K
UVXY icon
81
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$224M
$266K 0.11%
+10
New +$364K
CRM icon
82
Salesforce
CRM
$151B
$223K 0.09%
+1,000
New +$243K
SGMO
83
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$218K 0.09%
14,000
-26,400
-65% -$309K
TBHC
84
DELISTED
The Brand House Collective
TBHC
$192K 0.08%
10,750
-7,250
-40% -$99.1K
ET icon
85
Energy Transfer Partners
ET
$70.1B
$174K 0.07%
28,200
+11,000
+64% +$66.5K
KIN
86
DELISTED
Kindred Biosciences, Inc.
KIN
$172K 0.07%
+40,000
New +$163K
ADMS
87
DELISTED
Adamas Pharmaceuticals
ADMS
$135K 0.06%
31,236
– –
OBSV
88
DELISTED
ObsEva SA Ordinary Shares
OBSV
$104K 0.04%
50,000
– –
VBIV
89
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$99K 0.04%
1,200
+317
+36% +$27K
ACGN
90
DELISTED
Aceragen Inc
ACGN
$69K 0.03%
1,104
-5,079
-82% -$291K
AAPL icon
91
PUT
Apple
AAPL
$4.54T
– –
-2,000
Closed -$232K
CSCO icon
92
Cisco
CSCO
$457B
– –
-30,000
Closed -$1.18M
FCX icon
93
CALL
Freeport-McMoran
FCX
$90B
– –
-20,000
Closed -$313K
B
94
CALL
Barrick Mining
B
$61.5B
– –
-10,000
Closed -$281K
IBB icon
95
iShares Biotechnology ETF
IBB
$9.34B
– –
-10,000
Closed -$1.35M
IBM icon
96
IBM
IBM
$211B
– –
-7,845
Closed -$913K
INTC icon
97
CALL
Intel
INTC
$455B
– –
-7,500
Closed -$388K
MSFT icon
98
PUT
Microsoft
MSFT
$3.45T
– –
-10,000
Closed -$2.1M
MU icon
99
CALL
Micron Technology
MU
$930B
– –
-11,500
Closed -$540K
MU icon
100
PUT
Micron Technology
MU
$930B
– –
-25,000
Closed -$1.17M
1 2 3
4
5

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, DCF Advisers held 110 positions worth $242M, up 24% from $196M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

DCF Advisers deployed $26.1M of net new capital in Q4 2020, opening 24 new positions and adding to 21 existing holdings. Its largest new stake was Becton Dickinson: 10,250 shares worth $2.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $1.43M trimmed.

  • DCF Advisers's largest Q4 2020 buy was Becton Dickinson: 10,250 shares worth $2.5M.
  • DCF Advisers added most to AbbVie in Q4 2020, an estimated $1.63M increase.
  • DCF Advisers's biggest Q4 2020 reduction was Alphabet (Google) Class C, cutting an estimated $1.43M.
  • DCF Advisers fully exited iShares Biotechnology ETF in Q4 2020, selling an estimated $1.35M.
  • DCF Advisers's ten largest holdings make up 47% of its $242M portfolio in Q4 2020.
  • DCF Advisers opened 24 new positions and closed 20 in Q4 2020.
  • DCF Advisers's portfolio value rose 24% quarter-over-quarter to $242M.

Based on DCF Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.